Connecticut is joining at least nine other states suing drug maker Eli Lilly and Co. over the antipsychotic drug Zyprexa.
Attorney General Richard Blumenthal says Connecticut’s lawsuit seeks to recover more than $190 million that that state’s medical assistance program spent on Zyprexa over more than a decade.
The lawsuit accuses Indianapolis-based Eli Lilly of running an illegal marketing campaign to promote Zyprexa for unapproved off-label uses, including treating children.
Blumenthal says the campaign also concealed risks associated with the drug, including diabetes, weight gain and cardiovascular problems.
A court in Alaska is currently hearing that state’s lawsuit, and eight other states have sued as well.
A message seeking comment has been left with Eli Lilly.